{"id":"https://openalex.org/W2012368511","doi":"https://doi.org/10.1177/0269881112472558","title":"Combined NK 1 antagonism and serotonin reuptake inhibition: effects on emotional processing in humans","display_name":"Combined NK 1 antagonism and serotonin reuptake inhibition: effects on emotional processing in humans","alternate_titles":[],"publication_year":2013,"publication_date":"2013-02-12","ids":{"openalex":"https://openalex.org/W2012368511","doi":"https://doi.org/10.1177/0269881112472558","mag":"2012368511","pmid":"https://pubmed.ncbi.nlm.nih.gov/23407644"},"language":"en","primary_location":{"id":"doi:10.1177/0269881112472558","doi":"https://doi.org/10.1177/0269881112472558","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881112472558","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012368511"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012818091","display_name":"Catherine J. Harmer","orcid":"https://orcid.org/0000-0002-1609-8335","observed_orcids":["https://orcid.org/0000-0002-1609-8335"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catherine J Harmer","raw_affiliation_strings":["Department of Psychiatry, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025285378","display_name":"Gerry R. Dawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gerry R Dawson","raw_affiliation_strings":["P1vital Ltd, University of Oxford, Oxford, UK","#N# 2P1vital Ltd, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P1vital Ltd, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"#N# 2P1vital Ltd, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089441909","display_name":"Colin Trevor Dourish","orcid":"https://orcid.org/0000-0002-3403-6330","observed_orcids":["https://orcid.org/0000-0002-3403-6330"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Colin T Dourish","raw_affiliation_strings":["P1vital Ltd, University of Oxford, Oxford, UK","#N# 2P1vital Ltd, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P1vital Ltd, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"#N# 2P1vital Ltd, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037071869","display_name":"Elisa Favaron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elisa Favaron","raw_affiliation_strings":["Department of Psychiatry, University of Oxford, Oxford, UK","1Department of Psychiatry, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"1Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elizabeth Parsons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Parsons","raw_affiliation_strings":["Department of Psychiatry, University of Oxford, Oxford, UK","1Department of Psychiatry, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"1Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Monica Fiore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Fiore","raw_affiliation_strings":["Glaxosmithkline, Verona, Italy","#N# 3Glaxosmithkline, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"#N# 3Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112407370","display_name":"Mauro Zucchetto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mauro Zucchetto","raw_affiliation_strings":["Glaxosmithkline, Verona, Italy","#N# 3Glaxosmithkline, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"#N# 3Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032401216","display_name":"Angelo Bifone","orcid":"https://orcid.org/0000-0002-7423-3419","observed_orcids":["https://orcid.org/0000-0002-7423-3419"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angelo Bifone","raw_affiliation_strings":["Glaxosmithkline, Verona, Italy","#N# 3Glaxosmithkline, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"#N# 3Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021392198","display_name":"Italo Poggesi","orcid":"https://orcid.org/0000-0003-3079-6954","observed_orcids":["https://orcid.org/0000-0003-3079-6954"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Italo Poggesi","raw_affiliation_strings":["Glaxosmithkline, Verona, Italy","#N# 3Glaxosmithkline, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"#N# 3Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sofia Fernandes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sofia Fernandes","raw_affiliation_strings":["Glaxosmithkline, Verona, Italy","#N# 3Glaxosmithkline, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"#N# 3Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103079586","display_name":"Robert Alexander","orcid":"https://orcid.org/0000-0002-6889-2952","observed_orcids":["https://orcid.org/0000-0002-6889-2952"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Robert C Alexander","raw_affiliation_strings":["Glaxosmithkline, Verona, Italy","#N# 3Glaxosmithkline, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"#N# 3Glaxosmithkline, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037628078","display_name":"Guy M. Goodwin","orcid":"https://orcid.org/0000-0002-1426-2816","observed_orcids":["https://orcid.org/0000-0002-1426-2816"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Guy M Goodwin","raw_affiliation_strings":["Department of Psychiatry, University of Oxford, Oxford, UK","1Department of Psychiatry, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"1Department of Psychiatry, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":2.3128,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.85415403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"27","issue":"5","first_page":"435","last_page":"443"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.36010000109672546,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0731000006198883,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibition","display_name":"serotonin reuptake inhibition","score":0.8849999904632568},{"id":"https://openalex.org/keywords/serotonin-transporter-inhibition","display_name":"serotonin transporter inhibition","score":0.6779999732971191},{"id":"https://openalex.org/keywords/emotional-processing","display_name":"emotional processing","score":0.8059999942779541},{"id":"https://openalex.org/keywords/attentional-vigilance","display_name":"attentional vigilance","score":0.8270000219345093},{"id":"https://openalex.org/keywords/dot-probe-task","display_name":"dot-probe task","score":0.8669999837875366},{"id":"https://openalex.org/keywords/facial-expression-recognition","display_name":"facial expression recognition","score":0.9449999928474426},{"id":"https://openalex.org/keywords/emotional-memory","display_name":"emotional memory","score":0.9829999804496765},{"id":"https://openalex.org/keywords/citalopram","display_name":"citalopram","score":0.8790000081062317},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.4440000057220459},{"id":"https://openalex.org/keywords/acute-drug-effects","display_name":"acute drug effects","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.8327819108963013},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.7006655931472778},{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.6806568503379822},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6275984048843384},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5327902436256409},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5282099843025208},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5044037103652954},{"id":"https://openalex.org/C192769605","wikidata":"https://www.wikidata.org/wiki/Q1418914","display_name":"Vigilance (psychology)","level":2,"score":0.5025591850280762},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4221772849559784},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41788241267204285},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.41231200098991394},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25640174746513367},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.25594833493232727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25099435448646545},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23179727792739868},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.20680862665176392},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.15586933493614197},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15279695391654968},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004644","descriptor_name":"Emotions","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005149","descriptor_name":"Facial Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008568","descriptor_name":"Memory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010465","descriptor_name":"Perception","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015283","descriptor_name":"Citalopram","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D021641","descriptor_name":"Recognition, Psychology","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064729","descriptor_name":"Neurokinin-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/0269881112472558","doi":"https://doi.org/10.1177/0269881112472558","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881112472558","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:23407644","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23407644","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unito.it:2318/1692670","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/1692670","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W44741455","https://openalex.org/W154326007","https://openalex.org/W213417050","https://openalex.org/W1963945289","https://openalex.org/W1965507891","https://openalex.org/W1995167996","https://openalex.org/W2009684277","https://openalex.org/W2025221637","https://openalex.org/W2027207734","https://openalex.org/W2030071660","https://openalex.org/W2041484073","https://openalex.org/W2045030807","https://openalex.org/W2045618160","https://openalex.org/W2051037982","https://openalex.org/W2055098509","https://openalex.org/W2055505440","https://openalex.org/W2062190490","https://openalex.org/W2067240101","https://openalex.org/W2067422206","https://openalex.org/W2069236946","https://openalex.org/W2084988952","https://openalex.org/W2090514581","https://openalex.org/W2093839213","https://openalex.org/W2096266931","https://openalex.org/W2100141046","https://openalex.org/W2105190393","https://openalex.org/W2107125549","https://openalex.org/W2125228745","https://openalex.org/W2130892279","https://openalex.org/W2134189152","https://openalex.org/W2135286048","https://openalex.org/W2140799285","https://openalex.org/W2146356023","https://openalex.org/W2147351252","https://openalex.org/W2148181364","https://openalex.org/W2148905283","https://openalex.org/W2151786648","https://openalex.org/W2161749708","https://openalex.org/W2163072248","https://openalex.org/W2166281097","https://openalex.org/W2169235472","https://openalex.org/W2171562313","https://openalex.org/W2311274808","https://openalex.org/W2319900104","https://openalex.org/W2437324972"],"related_works":["https://openalex.org/W2171562313","https://openalex.org/W2003448276","https://openalex.org/W2115823610","https://openalex.org/W2061185429","https://openalex.org/W2055098509","https://openalex.org/W2050950253","https://openalex.org/W2107125549","https://openalex.org/W2163072248","https://openalex.org/W2166961718","https://openalex.org/W2045618160"],"abstract_inverted_index":{"BACKGROUND:":[0],"Synergistic":[1],"effects":[2,52,158],"of":[3,24,31,41,53,56,80,90,113,148,153,174,177,188],"NK\u2081":[4,27],"receptor":[5,28],"antagonism":[6],"combined":[7],"with":[8,166],"serotonin":[9,33,67],"reuptake":[10,68],"inhibition":[11],"have":[12,43],"been":[13,45],"reported":[14],"in":[15,38,61,98,124,181],"preclinical":[16],"models.":[17],"GSK424887":[18,57,94,149],"is":[19],"a":[20,75,182],"selective":[21,66],"competitive":[22],"antagonist":[23],"the":[25,32,51,87,99,125,171,175,189],"human":[26,39],"and":[29,105,116,120,191],"inhibitor":[30,69],"transporter.":[34],"However,":[35],"its":[36],"actions":[37],"models":[40],"depression":[42],"not":[44,160],"assessed.":[46],"METHODS:":[47],"This":[48,169],"study":[49],"explored":[50],"acute":[54,146],"administration":[55,147,187],"compared":[58],"to":[59,102,162,198],"placebo":[60],"healthy":[62],"male":[63],"volunteers.":[64],"The":[65],"(SSRI)":[70],"citalopram":[71,110],"was":[72,84,170],"used":[73],"as":[74],"positive":[76,104,122],"control.":[77],"A":[78],"battery":[79,176],"emotional":[81,139,154,178],"processing":[82,155,179],"tasks":[83,180],"given":[85],"at":[86],"peak":[88],"time":[89],"drug":[91,131],"effect.":[92],"RESULTS:":[93],"enhanced":[95,111],"attentional":[96],"vigilance":[97],"dot-probe":[100],"task":[101],"both":[103],"negative":[106],"stimuli.":[107],"By":[108],"contrast,":[109],"perception":[112],"angry,":[114],"sad":[115],"happy":[117],"facial":[118,126],"expressions":[119],"increased":[121],"bias":[123],"expression":[127],"recognition":[128],"task.":[129],"Neither":[130],"significantly":[132],"affected":[133],"emotion":[134],"potentiated":[135],"startle":[136],"responses":[137],"or":[138],"memory.":[140],"CONCLUSIONS:":[141],"These":[142],"results":[143],"suggest":[144],"that":[145],"modulated":[150],"some":[151],"aspects":[152],"but":[156],"these":[157],"were":[159],"similar":[161],"those":[163],"seen":[164],"previously":[165],"antidepressant":[167],"agents.":[168],"first":[172],"use":[173],"Phase":[183],"1":[184],"study.":[185],"Repeated":[186],"test":[190],"active":[192],"control":[193],"drugs":[194],"may":[195],"be":[196],"needed":[197],"reliably":[199],"characterise":[200],"their":[201],"effects.":[202]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012368511","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
